Diagnostic labs and drug developers are in a constant search for cheaper, better, faster test results, and SQI Diagnostics (OTCQX: SQIDF) is focused on meeting this demand. The company reduces the timeline for urgently-needed test results and the amount of labor needed, all without forfeiting quality.
SQI Diagnostics is a life sciences and diagnostics company that supports better health care through the development and marketing of technologies and products that propel faster and more accurate advanced multiplexing diagnostics. From SQI’s base in Toronto, a team of expert scientists develops custom research and diagnostic assays that are multiplexed to consolidate and automate many individual tests into one.
The company’s portfolio of automated systems and platforms includes:
- sqidworks diagnostic platform, a fully-automated microarray processing and analytical system;
- sqidlite bench-top diagnostic system, a fully automated bench top microarray processing system; and
- sqid-X, a semi-automated bench-top platform.
SQI delivers these market-leading, quality tests and automated systems for customers who need to measure a broad range of biomarkers in blood and/or other common sample types. Its team supports these customers, who have the skills and ideas to considerably improve quality of life, by providing the tools and services that will bring those ideas to the market sooner.
SQI has 12 patents and the knowledge base to simplify the multiplex testing needs of three key markets, including pharmaceutical and biotechnology drug development, human diagnostic testing and animal health diagnostic testing.
The company’s multiplexed tests and automated systems, combined with its full service product commercialization, hands-free processing and automated data analysis and reporting, shorten the work flow for these markets. This way, the SQI team assists in generating more comprehensive data. By delivering many diagnostic results from single tests and single specimens while using an automated process, SQI increases sample throughput; reduces time, cost and chance for human error; and provides excellent data quality.
To take a closer look at this company, visit www.sqidiagnostics.com
This post first appeared on Monaker Group, Inc. (MKGI) Carves Niche In Explosi, please read the originial post: here